KMO, kynurenine 3-monooxygenase, 8564

N. diseases: 44; N. variants: 2
Disease: Psychotic Disorders ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0033975
Disease: Psychotic Disorders
Psychotic Disorders 		0.030 GeneticVariation group BEFREE Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders. 28187857 2017
CUI: C0033975
Disease: Psychotic Disorders
Psychotic Disorders 		0.030 Biomarker group BEFREE Contributing to enhanced production of kynurenic acid, the expression and enzyme activity of kynurenine 3-monooxygenase (KMO) are reduced in schizophrenia and in bipolar patients with a history of psychosis. 27245499 2017
CUI: C0033975
Disease: Psychotic Disorders
Psychotic Disorders 		0.030 GeneticVariation group BEFREE Some of the psychosis-only-associated SNPs found in the d-amino acid oxidase activator (DAOA) and the kynurenine 3-monooxygenase (KMO) genes have previously been reported to be associated with schizophrenia. 26142836 2015